Ignite Creation Date:
2024-05-06 @ 4:15 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04922515
Status:
UNKNOWN
Last Update Posted:
2021-06-10
First Post:
2021-05-31
Brief Title:
Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes
Sponsor:
University Medical Center Goettingen
Organization:
University Medical Center Goettingen
Study Overview
Official Title:
Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes
Status:
UNKNOWN
Status Verified Date:
2021-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PDA-MAPS
Brief Summary:
The prospective clinical trial PDA-MAPS - Pancreatic ductal adenocarcinoma - Microbiome as Predictor of Subtypes aims to investigate the prognostic and predictive power of the orointestinal and tumoral microbiome in PDAC patients and associate findings with genetic transcriptional and clinical data in particular with treatment response
Detailed Description:
The prospective clinical trial PDA-MAPS - Pancreatic ductal adenocarcinoma - Microbiome as Predictor of Subtypes aims to investigate the prognostic and predictive power of the orointestinal and tumoral microbiome in PDAC patients and associate findings with genetic transcriptional and clinical data in particular with treatment response Patients with histologically confirmed PDA are enrolled at primary diagnosis and prior to oncological or surgical treatment Rectal and buccal microbiome swabs as well as detailed clinical records are obtained from all patients Following DNA extraction both 16S rRNA and metagenomic sequencing will be performed using ONT sequencing platform All data and clinical records are centrally stored visualized and integrated via tranSMART and SEEK platforms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None